In the present, several serum cancer biomarkers have been used in clinic, such as carcinoembryonic antigen (CEA), α-fetoprotein (AFP), and carbohydrate antigens 125 and 19-9 (CA 125 and CA 19-9) [4–7]. This evidence concerns the gene CEACAM5 and cancer.